IP Library Granted Patent US 10,004,644
Granted Patent B2
US 10,004,644 · App. 14/055,481 · Granted Jun 26, 2018

Absorbable, reduced-pressure manifolds and systems

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,004,644
App. No.
14/055,481
Granted
Jun 26, 2018
Kind
B2
Abstract

A reduced-pressure treatment system includes an isolation device for isolating a tissue site from surrounding tissue for reduced-pressure treatment that is formed from a first material having a first bio-absorption term and at least a second material having a second and different bio-absorption term. The different materials allow the isolation device initially to function well for reduced-pressure treatment and then to experience degradation at a quicker pace which facilitates healing. In addition, a reduced-pressure manifold for treating a tissue site is presented that includes a flexible barrier member formed from a first material, which has a first bio-absorption term and formed with a first plurality of apertures; a second material, which has a second bio-absorption term, disposed within the plurality of apertures; wherein the first bio-absorption term is greater than the second bio-absorption term; and a reduced-pressure delivery member coupled to the barrier member for delivering reduced pressure to the second surface of the barrier member during reduced-pressure treatment.

Claims (41)

1. A system for treating a tissue site comprising bone tissue, comprising:

an isolation device for isolating a tissue site from surrounding tissue for reduced-pressure treatment, the isolation device comprising:

a first material having a first surface,

a second surface adapted to face the tissue site and further having a first bio-absorption term (BA 1 ), and further comprising a second material having at least a first portion extending between the first surface and the second surface of the first material and further having a second bio-absorption term (BA 2 ) in the range from more than one day to not more than 14 days, wherein the first bio-absorption term is greater than the second bio-absorption term (BA 1 > BA 2 ), and

a spine portion forming a recessed arcuate channel,

a reduced-pressure source for providing a reduced pressure to treat the bone tissue at the tissue site; and

a reduced-pressure delivery conduit configured to be positioned within a portion of the recessed arcuate channel and to fluidly couple the isolation device and the reduced-pressure source for delivering a reduced pressure over the second surface via an orifice positioned along a longitudinal axis of the reduced-pressure delivery conduit.

2. The system of claim 1 wherein the isolation device comprises a flexible barrier member, the flexible barrier member comprising: a barrier body formed from the first material and wherein the flexible barrier member is formed with a first plurality of apertures; and wherein the first portion of the second material is disposed within the first plurality of apertures and operable to form a temporary seal.

3. The system of claim 1 wherein the isolation device comprises a flexible barrier member, the flexible barrier member comprising: a barrier body formed from the first material and wherein a plurality of projections extend from the second, tissue-facing surface, the plurality of projections formed from at least a second portion of the second material.

4. The system of claim 3 wherein the flexible barrier member is formed with a first plurality of apertures, and wherein the first portion of the second material is disposed within the first plurality of apertures and is operable to form a temporary seal.

5. The system of claim 1 ,

wherein the isolation device comprises a flexible barrier member, the flexible barrier member comprising: a barrier body formed from the first material and wherein the flexible barrier member is formed with a first plurality of apertures;

wherein the first portion of the second material is disposed within the first plurality of apertures and operable to form a temporary seal;

wherein the flexible barrier member further comprises a third material having a third bio-absorption term (BA 3 );

wherein the flexible barrier member is formed with a second plurality of apertures;

wherein the third material is disposed within the second plurality of apertures; and

wherein the first bio-absorption term is greater than the third bio-absorption term (BA 1> BA 3 ).

6. The system of claim 1 wherein the isolation device comprises a woven fabric comprising a first thread material formed from the first material and a second thread material formed from the second material; and wherein the first material has the first bio-absorption term and the second material has the second bio-absorption term.

7. The system of claim 1 wherein isolation device comprises a barrier body having a plurality of a first material units formed from the first material and a plurality of second material units formed from the second material; wherein the plurality of a first material units and the plurality of second material units laterally abut one another.

8. The system of claim 1 wherein isolation device comprises a barrier body formed from the first material and formed with a plurality of apertures; and a coating layer of the second material disposed on the first surface of the barrier body and disposed in the plurality of apertures.

9. The system of claim 1 wherein the isolation device comprises:

a flexible barrier member formed from the first material and wherein the barrier member is formed with a first plurality of apertures; and

wherein the second material is disposed within the first plurality of apertures and operable to form a temporary seal.

10. The system of claim 1 wherein the isolation device comprises a flexible barrier member, the flexible barrier member comprises the spine portion, a first wing and a second wing, wherein the first wing and the second wing are positioned along opposite sides of the spine portion.

11. A method for treating a tissue site with reduced pressure, the method comprising:

positioning a reduced-pressure manifold for isolating a tissue site from surrounding tissue for reduced-pressure treatment proximate the tissue site with a reduced-pressure delivery member, the reduced-pressure manifold comprising:

a first material having a first surface,

a second surface adapted to face the tissue site and further having a first bio-absorption term (BA 1 ), and further comprising a second material having at least a first portion extending between the first surface and the second surface of the first material and further having a second bio-absorption term (BA 2 ) in the range from more than one day to not more than 14 days, and

a spine portion forming a recessed arcuate channel,

positioning a reduced-pressure delivery conduit within a portion of the recessed arcuate channel;

providing reduced-pressure to the reduced-pressure manifold from a reduced pressure source via an orifice positioned along a longitudinal axis of the reduced-pressure delivery conduit;

removing the reduced-pressure delivery conduit;

removing the reduced-pressure delivery member;

allowing the first material to absorb within a first bio-absorption term (BA 1 ); and

allowing the second material to absorb within a second bio-absorption term (BA 2 ) that is less than the first bio-absorption term (BA 2< BA 1 ).

12. The method of claim 11 further comprising: fluidly coupling the reduced-pressure delivery member to the reduced-pressure manifold.

13. The method of claim 12 further comprising: following application of reduced pressure and prior to allowing the first and second materials to absorb, removing the reduced-pressure delivery member.

14. The method of claim 11 wherein positioning the reduced-pressure manifold further comprises using the reduced-pressure delivery member to deploy the reduced-pressure manifold proximate the tissue site.

15. The method of claim 11 wherein the reduced-pressure manifold comprises:

a barrier member formed from the first material and having a first surface and a second, tissue-facing surface and wherein the barrier member is formed with a first plurality of apertures, and

wherein the second material is disposed within the first plurality of apertures and is operable to form a temporary seal.

Assignments (7)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 1, 2024
From: 3M INNOVATIVE PROPERTIES COMPANY
To: SOLVENTUM INTELLECTUAL PROPERTIES COMPANY
Reel/Frame 066436/0063 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 31, 2023
From: KCI LICENSING, INC.
To: 3M INNOVATIVE PROPERTIES COMPANY
Reel/Frame 064790/0085 →
RELEASE OF SECURITY INTEREST IN PATENTS Recorded Nov 7, 2019
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: KCI USA, INC.; KCI LICENSING, INC.
Reel/Frame 050966/0547 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 19, 2018
From: KAGAN, JONATHAN
To: KCI LICENSING, INC.
Reel/Frame 045585/0033 →
RELEASE OF SECURITY INTEREST REEL/FRAME 040098/0268 Recorded Feb 8, 2017
From: WILMINGTON TRUST
To: KCI USA, INC.
Reel/Frame 041666/0320 →
LIMITED THIRD LIEN INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Oct 7, 2016
From: KCI USA, INC.; LIFECELL CORPORATION; KCI LICENSING, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 040291/0237 →
SECOND LIEN SECURITY AGREEMENT Recorded Sep 21, 2016
From: KCI USA, INC.; LIFECELL CORPORATION; KCI LICENSING, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 040098/0268 →